HLA-B*15:02 Gene-Related Toxicity & Side Effects of Epilepsy Drugs
The HLA-B15:02 Gene-Related Toxicity & Side Effects of Epilepsy Drugs Test Card is designed for laboratory research to detect the HLA-B15:02 gene variant, which is associated with an increased risk of severe adverse reactions to certain anti-epileptic drugs (AEDs), such as carbamazepine and phenytoin. The presence of this gene variant is linked to potentially life-threatening conditions, including Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN). This test card offers a rapid and reliable method for identifying this genetic variant in research samples, aiding studies on genetic influences in drug toxicity and personalized medicine.
Overview
The HLA-B15:02 Gene-Related Toxicity & Side Effects of Epilepsy Drugs Test Card provides a fast and accurate tool for detecting the HLA-B15:02 gene variant in laboratory research. This test is essential for studying the genetic basis of adverse drug reactions and contributes to the development of safer epilepsy drug therapies. By enabling researchers to identify individuals at risk of severe side effects, the test card supports advancements in personalized medicine and the optimization of drug treatment strategies.
Rapid Detection: Provides result in 30 minutes
Easy-to-Use: Simple one-step process, compact and easy to store
Non-Invasive: Detects HLA-B* 15:02 Gene related toxicity in samples without the need for invasive procedure
Use: Suitable for use in laboratory settings
Specification
Sample Type: DNA
Application: Research
Time to result: 30 minutes
Packaging: Available in boxes of 4, 8, or 12 tests
Storage: Store LAMP reagent in freezer until use
Precaution
For research use only.
Use within 10 minutes of opening the foil pouch.
Do not use if pouch is damaged or seal is broken.
Do not use after expiration date.
How to Use / Instructions
Please refer to the included instructions for a detailed, step-by-step guide on how to properly perform the test.
Overview
The HLA-B15:02 Gene-Related Toxicity & Side Effects of Epilepsy Drugs Test Card provides a fast and accurate tool for detecting the HLA-B15:02 gene variant in laboratory research. This test is essential for studying the genetic basis of adverse drug reactions and contributes to the development of safer epilepsy drug therapies. By enabling researchers to identify individuals at risk of severe side effects, the test card supports advancements in personalized medicine and the optimization of drug treatment strategies.
Rapid Detection: Provides result in 30 minutes
Easy-to-Use: Simple one-step process, compact and easy to store
Non-Invasive: Detects HLA-B* 15:02 Gene related toxicity in samples without the need for invasive procedure
Use: Suitable for use in laboratory settings
Specification
Sample Type: DNA
Application: Research
Time to result: 30 minutes
Packaging: Available in boxes of 4, 8, or 12 tests
Storage: Store LAMP reagent in freezer until use
Precaution
For research use only.
Use within 10 minutes of opening the foil pouch.
Do not use if pouch is damaged or seal is broken.
Do not use after expiration date.
How to Use / Instructions
Please refer to the included instructions for a detailed, step-by-step guide on how to properly perform the test.
Related Products
